AstraZeneca, drugmakers release promising cancer data

Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! I’m back in New York City after spending the last weekend in … Read more

AstraZeneca CEO believes the company can almost double revenue by 2030

AstraZeneca CEO Pascal Soriot explained in a Tuesday interview with CNBC’s Jim Cramer why the drugmaker believes it can almost double revenue by 2030. “Biology is complicated, and we’re never sure of anything. But we have a great level of confidence we can get there, and I think this target forces us to think creatively … Read more

This up-and-coming cancer treatment could be a $25 billion market opportunity

Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called targeted radiopharmaceutical therapy. It essentially delivers radiation directly into tumors by attaching a radioactive particle to a targeting molecule. RBC Capital Markets sees a $25 … Read more

AstraZeneca to boost revenue, release new medicines by 2030

The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. Costfoto | Future Publishing | Getty Images LONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total revenue to $80 billion by 2030 — up 75% from $45.8 billion in 2023. “We have … Read more

AstraZeneca to withdraw Covid vaccine worldwide, citing drop in demand

In this photo illustration a covid-19 vaccine is seen with the AstraZeneca logo in the background. (Photo Illustration by Nikos Pekiaridis/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined. The so-called Vaxzevria vaccine was developed … Read more

Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance

The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. Scott Olson | Getty Images Novo Nordisk and Eli Lilly have long dominated the rapidly growing weight loss drug market, but their duopoly is closer than ever to facing a threat from a new rival.  Amgen … Read more

FTC challenges patents held by drugmakers, including for Ozempic

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023.  Lee Smith | Reuters The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name drugs, including Novo Nordisk’s blockbuster diabetes drugs Ozempic, Saxenda and Victoza. … Read more

Weight loss, diabetes drug ad spending tops $1 billion

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Drugmakers spent big on advertisements for weight loss and diabetes treatments last year … Read more

Drugmakers are capping inhaler prices at $35

A woman using an inhaler.  BSIP | Universal Images Group | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Inhalers will soon get a whole lot cheaper for some Americans.  Three of the world’s largest inhaler makers have agreed to cap the … Read more

Nvidia stomps the bears. Jim Cramer on struggling stocks Starbucks, Abbott

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets rebound as Nvidia goes green: … Read more